Kathleen Mommaerts, doctoral candidate and scientist within the Biospecimen Science Research Group at IBBL, and Dr Monica Marchese, Translational Biomarker Group Leader at IBBL, developed a novel quality assessment tool to verify the integrity and fitness-for-purpose of cerebrospinal fluid (CSF) biospecimens to be used in the context of Alzheimer’s disease research.
The team had previously observed that, when cerebrospinal fluid was stored at -20 °C for 3 months, the integrity of certain proteins commonly found in CSF was compromised. Specifically, protein cystatin C, which is involved in Alzheimer’s disease and is considered as a brain tissue biomarker in this disorder, showed a particular breakage that was not however reported when CSF was stored at -80 °C.
“We therefore aimed to develop an immunoassay that would act as quality assessment tool to detect this specific N-terminal octapeptide cleavage of cystatin C that occurs when CSF is stored at -20 °C”, explains Kathleen Mommaerts, corresponding author of the study.
The researchers therefore devised a monoclonal antibody as well as a specific type of ELISA assay. The former assay quantifies the intact uncleaved protein, while the latter quantifies the total cystatin C present in the CSF sample (in both cleaved and uncleaved forms). The team calculated the ratio of these concentrations to assess the extent of cleavage of cystatin C and subsequently validated and applied the novel assay in a short-term (up to 4 weeks) and mid-term (up to one year) stability study of CSF stored at 4°C, -20°C, -80°C and in liquid nitrogen. They observed that the ratio of truncated protein was only modified following storage at -20 °C, most likely due to an increased susceptibility of the protein to the activity of protein-degrading enzymes at -20 °C, thereby confirming the validity of the assay in detecting this particular type of molecular damage under these specific storage conditions.
“Using this simple novel double assay, researchers will be able to easily and quickly confirm that their CSF biospecimens are intact and fit for the purpose of their intended research, including biomarker discovery and validation in the context of neurodegenerative and neuroinflammatory diseases such as multiple sclerosis and Alzheimer’s”, explains Kathleen Mommaerts.
“Indeed, biomarker discovery and validation critically depend on the molecular quality of the biospecimens used. Suboptimal long-term storage conditions of CSF can induce molecular degradation and introduce bias in biomarker studies, thereby compromising the validity of research results and hindering the development of new therapies for patients. Storing CSF samples at -80 °C therefore increases the stability of CSF protein biomarkers, compared to freezing at -20 °C, thereby ensuring their quality”, she concludes.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
5 months 27 days
This cookie is set by the Google recaptcha service to identify bots to protect the website against malicious spam attacks.
Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Analytics" category .
The cookie is set by the GDPR Cookie Consent plugin to record the user consent for the cookies in the category "Functional".
Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Necessary" category .
Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Others".
Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Performance".
Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
The JSESSIONID cookie is used by New Relic to store a session identifier so that New Relic can monitor session counts for an application.
This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
Analytical cookies are used to understand how visitors interact with the website. These cookies provide information on metrics such as number of visitors, bounce rate, traffic source, etc.
The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
This cookie is installed by Google Analytics.
Set by Google to distinguish users.
Installed by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
Linkedin set this cookie to store information about the time a sync took place with the lms_analytics cookie.
YouTube sets this cookie via embedded youtube-videos and registers anonymous statistical data.